BayesianTrial: Bayesian Decision-Making for Clinical Trials
Provides tools for Bayesian decision-making in single-arm
phase II clinical trials with binary efficacy endpoints. Uses
Beta-binomial models to calculate posterior probabilities that the
response rate exceeds a prespecified reference value and to estimate
predictive probabilities of meeting final-analysis success criteria.
Evaluates the frequentist operating characteristics of two-stage
designs with posterior-probability-based stopping rules, including
type I error rates, statistical power, and probabilities of early
stopping for efficacy or futility, using Monte Carlo simulation.
For methodological background, see Thall and Simon (1994)
<doi:10.2307/2533377> and Lee and Liu (2008)
<doi:10.1177/1740774508089279>.
Documentation:
Downloads:
Linking:
Please use the canonical form
https://CRAN.R-project.org/package=BayesianTrial
to link to this page.